Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Spondylitis, Ankylosing; Spondyloarthritis; Systemic Lupus Erythematosus; Sjogren's Syndrome; Systemic Sclerosis; Idiopathic Inflammatory Myopathies; Vasculitis, Systemic; Juvenile Idiopathic Arthritis; Dermatomyositis, Juvenile Interventions: Biological: Recombinant Herpes Zoster Vaccine (RZV); Other: MTX Discontinuation; Other: MMF Discontinuation; Other: Placebo; Other: MTX maintain; Other: MMF maintain Sponsors: University of Sao Paulo General Hospital; GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials
Add-on Intravenous Immunoglobulins in Early Myositis
Conditions: Inflammatory Myopathy, Idiopathic; Dermatomyositis; Antisynthetase Syndrome; Immune-Mediated Necrotizing Myopathy; Polymyositis; Myositis Interventions: Drug: Immune Globulin Intravenous (Human); Drug: Placebo Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Princess Beatrix Muscle Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
Conditions: Dermatomyositis; Polymyositis; Idiopathic Inflammatory Myopathies Interventions: Drug: Froniglutide; Drug: Placebo Sponsor: Immunoforge Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
Add-on Intravenous Immunoglobulins in Early Myositis
Conditions: Inflammatory Myopathy, Idiopathic; Dermatomyositis; Antisynthetase Syndrome; Immune-Mediated Necrotizing Myopathy; Polymyositis; Myositis Interventions: Drug: Immune Globulin Intravenous (Human); Drug: Placebo Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Princess Beatrix Muscle Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
Conditions: Dermatomyositis; Polymyositis; Idiopathic Inflammatory Myopathies Interventions: Drug: Froniglutide; Drug: Placebo Sponsor: Immunoforge Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials